Altered regulation of calcium channels and exocytosis in single human pheochromocytoma cells.
We established primary cultures of human pheochromocytoma chromaffin cells. We then tried to find what mechanism of their secretory apparatus could be altered to produce the massive release of catecholamines into the circulation and the subsequent hypertensive crisis observed in patients suffering this type of tumor. Their whole-cell Ca2+ channel currents could be pharmacologically separated into components similar to those found in normal human adrenal chromaffin cells: 20% L-type, 30% N-type, and 50% P/Q-type Ca2+ channels. However, modulation of the channels by exogenous or endogenous ATP and opioids, via a G-protein membrane-delimited pathway, was deeply altered; some cells having no modulation or very little modulation alternated with others having normal modulation. This may be the cause of the uncontrolled secretory response, measured amperometrically at the single-cell level. Some cells secreted for long time periods and were insensitive to nifedipine (L-type channel blocker) or to omega-conotoxin MVIIC (N/P/Q-type channel blocker), while others were highly sensitive to nifedipine and partially sensitive to omega-conotoxin MVIIC. Alteration of the autocrine/paracrine modulation of Ca2+ channels may lead to indiscriminate Ca2+ entry and exacerbate catecholamine release responses in human pheochromocytoma cells.
Hernández-Guijo
J M
JM
Instituto Teófilo Hernando, Departamento de Farmacología, facultad de Medicina, Universidad Autónoma de Madrid, Spain.
Gandía
L
L
Cuchillo-Ibáñez
I
I
Albillos
A
A
Novalbos
J
J
Gilsanz
F
F
Larrañaga
E
E
de Pascual
R
R
Abad
F
F
García
A G
AG
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000310:Adrenal Gland Neoplasms / Q000473:pathology / Q000503:physiopathology*; D000328:Adult; D001464:Barium / Q000502:physiology; D015220:Calcium Channels / Q000378:metabolism* / Q000502:physiology; D019439:Chromaffin Cells / Q000378:metabolism / Q000502:physiology*; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism; D004553:Electric Conductivity; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / Q000494:pharmacology; D020881:Enkephalin, D-Penicillamine (2,5)- / Q000494:pharmacology; D004837:Epinephrine / Q000097:blood; D005089:Exocytosis / Q000502:physiology*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood; D010625:Phenylethanolamine N-Methyltransferase / Q000378:metabolism; D010673:Pheochromocytoma / Q000473:pathology / Q000503:physiopathology*; D014407:Tumor Cells, Cultured
D015220:Calcium Channels; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; D001464:Barium; D020881:Enkephalin, D-Penicillamine (2,5)-; D000255:Adenosine Triphosphate; D004299:Dopamine beta-Hydroxylase; D010625:Phenylethanolamine N-Methyltransferase; D009638:Norepinephrine; D004837:Epinephrine